Cargando…

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid

BACKGROUND: Immunoglobulin G (IgG) effector functions are regulated by the composition of glycans attached to a conserved N-glycosylation site in the Fc part. Intrathecal production of IgG, especially IgG1, is a hallmark of multiple sclerosis (MS), but nothing is known about IgG Fc glycosylation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wuhrer, Manfred, Selman, Maurice H. J., McDonnell, Liam A., Kümpfel, Tania, Derfuss, Tobias, Khademi, Mohsen, Olsson, Tomas, Hohlfeld, Reinhard, Meinl, Edgar, Krumbholz, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683913/
https://www.ncbi.nlm.nih.gov/pubmed/26683050
http://dx.doi.org/10.1186/s12974-015-0450-1
_version_ 1782406112448872448
author Wuhrer, Manfred
Selman, Maurice H. J.
McDonnell, Liam A.
Kümpfel, Tania
Derfuss, Tobias
Khademi, Mohsen
Olsson, Tomas
Hohlfeld, Reinhard
Meinl, Edgar
Krumbholz, Markus
author_facet Wuhrer, Manfred
Selman, Maurice H. J.
McDonnell, Liam A.
Kümpfel, Tania
Derfuss, Tobias
Khademi, Mohsen
Olsson, Tomas
Hohlfeld, Reinhard
Meinl, Edgar
Krumbholz, Markus
author_sort Wuhrer, Manfred
collection PubMed
description BACKGROUND: Immunoglobulin G (IgG) effector functions are regulated by the composition of glycans attached to a conserved N-glycosylation site in the Fc part. Intrathecal production of IgG, especially IgG1, is a hallmark of multiple sclerosis (MS), but nothing is known about IgG Fc glycosylation in MS and in cerebrospinal fluid (CSF) in general. METHODS: We applied mass spectrometry of tryptic Fc glycopeptides to analyze IgG Fc glycosylation (sialylation, galactosylation, fucosylation, and bisecting N-acetylglucosamine (GlcNAc)) in 48 paired CSF and serum samples from adult patients with MS or a first demyelinating event highly suggestive of MS (designated as MS cases), and from healthy volunteers and patients with other non-inflammatory diseases (control group). p values were adjusted for multiple testing. RESULTS: Our experiments revealed four main results. First, IgG1 glycosylation patterns were different in CSF vs. serum, in the MS group and even in control donors without intrathecal IgG synthesis. Second, in MS patients vs. controls, IgG1 glycosylation patterns were altered in CSF, but not in serum. Specifically, in CSF from the MS group, bisecting GlcNAc were elevated, and afucosylation and galactosylation were reduced. Elevated bisecting GlcNAc and reduced galactosylation are known to enhance IgG effector functions. Third, hypothesis-free regression analysis revealed that alterations of afucosylation and bisecting GlcNAc in CSF from MS cases peaked 2–3 months after the last relapse. Fourth, CSF IgG1 glycosylation correlated with the degree of intrathecal IgG synthesis and CSF cell count. CONCLUSIONS: The CNS compartment as well as the inflammatory milieu in MS affect IgG1 Fc glycosylation. In MS, the CSF IgG1 glycosylation has features that enhance Fc effector functions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-015-0450-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4683913
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46839132015-12-19 Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid Wuhrer, Manfred Selman, Maurice H. J. McDonnell, Liam A. Kümpfel, Tania Derfuss, Tobias Khademi, Mohsen Olsson, Tomas Hohlfeld, Reinhard Meinl, Edgar Krumbholz, Markus J Neuroinflammation Research BACKGROUND: Immunoglobulin G (IgG) effector functions are regulated by the composition of glycans attached to a conserved N-glycosylation site in the Fc part. Intrathecal production of IgG, especially IgG1, is a hallmark of multiple sclerosis (MS), but nothing is known about IgG Fc glycosylation in MS and in cerebrospinal fluid (CSF) in general. METHODS: We applied mass spectrometry of tryptic Fc glycopeptides to analyze IgG Fc glycosylation (sialylation, galactosylation, fucosylation, and bisecting N-acetylglucosamine (GlcNAc)) in 48 paired CSF and serum samples from adult patients with MS or a first demyelinating event highly suggestive of MS (designated as MS cases), and from healthy volunteers and patients with other non-inflammatory diseases (control group). p values were adjusted for multiple testing. RESULTS: Our experiments revealed four main results. First, IgG1 glycosylation patterns were different in CSF vs. serum, in the MS group and even in control donors without intrathecal IgG synthesis. Second, in MS patients vs. controls, IgG1 glycosylation patterns were altered in CSF, but not in serum. Specifically, in CSF from the MS group, bisecting GlcNAc were elevated, and afucosylation and galactosylation were reduced. Elevated bisecting GlcNAc and reduced galactosylation are known to enhance IgG effector functions. Third, hypothesis-free regression analysis revealed that alterations of afucosylation and bisecting GlcNAc in CSF from MS cases peaked 2–3 months after the last relapse. Fourth, CSF IgG1 glycosylation correlated with the degree of intrathecal IgG synthesis and CSF cell count. CONCLUSIONS: The CNS compartment as well as the inflammatory milieu in MS affect IgG1 Fc glycosylation. In MS, the CSF IgG1 glycosylation has features that enhance Fc effector functions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-015-0450-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-18 /pmc/articles/PMC4683913/ /pubmed/26683050 http://dx.doi.org/10.1186/s12974-015-0450-1 Text en © Wuhrer et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wuhrer, Manfred
Selman, Maurice H. J.
McDonnell, Liam A.
Kümpfel, Tania
Derfuss, Tobias
Khademi, Mohsen
Olsson, Tomas
Hohlfeld, Reinhard
Meinl, Edgar
Krumbholz, Markus
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
title Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
title_full Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
title_fullStr Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
title_full_unstemmed Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
title_short Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
title_sort pro-inflammatory pattern of igg1 fc glycosylation in multiple sclerosis cerebrospinal fluid
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683913/
https://www.ncbi.nlm.nih.gov/pubmed/26683050
http://dx.doi.org/10.1186/s12974-015-0450-1
work_keys_str_mv AT wuhrermanfred proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT selmanmauricehj proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT mcdonnellliama proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT kumpfeltania proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT derfusstobias proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT khademimohsen proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT olssontomas proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT hohlfeldreinhard proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT meinledgar proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid
AT krumbholzmarkus proinflammatorypatternofigg1fcglycosylationinmultiplesclerosiscerebrospinalfluid